This kit is intended for in vitro detection of Candida Albicans nucleic acid in vaginal discharge and sputum samples.
Epidemiology
Candida species is the largest normal fungal flora in the human body. It exists widely in the respiratory tract, digestive tract, urogenital tract and other organs that communicate with the outside world. Generally, it is not pathogenic and belongs to opportunistic pathogenic bacteria. Due to the extensive application of immunosuppressant and a large number of broad-spectrum antibiotics, as well as tumor radiotherapy, chemotherapy, invasive treatment, organ transplantation, the normal flora is imbalanced and candida infection occurs in the genitourinary tract and respiratory tract.
Candida infection of the genitourinary tract can make women suffer from Candida vulva and vaginitis, which seriously affects their life and work. The incidence of genital tract candidiasis is increasing year by year, among which female genital tract Candida infection accounts for about 36%, and male genital tract Candida infection accounts for about 9%, among them, Candida albicans (CA) is the mainly infection, account for about 80%. Fungal infection, typically Candida albicans, is an important cause of hospital-acquired death, and CA infection accounts for about 40% of ICU patients. Among all the visceral fungal infections, pulmonary fungal infections are the most common, and the trend is increasing year by year. Early diagnosis and identification of pulmonary fungal infections are of great clinical significance.
Technical Parameters
Storage - ≤-18℃
Shelf-life - 12 months
Specimen Type - Vaginal discharge, Sputum
Ct - ≤38
CV - ≤5.0%
LoD - 1×103Copies/mL